Aim: The “2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid
Hemorrhage” replaces the 2012 “Guidelines for the Management of Aneurysmal …

Abstract Purpose of Review Aneurysmal subarachnoid hemorrhage remains a devastating
disease process despite medical advances made over the past 3 decades. Much of the …

Abstract Purpose of Review Over the last years, the focus of clinical and animal research in
subarachnoid hemorrhage (SAH) shifted towards the early phase after the bleeding based …

Background Inflammation is a potential crucial factor in the pathogenesis of subarachnoid
hemorrhage (SAH). Circulating microRNAs (miRNAs) are involved in the regulation of …

Aneurysmal subarachnoid haemorrhage is a neurological syndrome with complex systemic
complications. The rupture of an intracranial aneurysm leads to the acute extravasation of …

Over the last two decades, neurological researchers have uncovered many
pathophysiological mechanisms associated with subarachnoid haemorrhage (SAH), with …

Only a few types of inflammasomes have been described in central nervous system cells.
Among these, the absent in melanoma 2 (AIM2) inflammasome is primarily found in …

Subarachnoid hemorrhage (SAH) affects 30,000 people in the Unites States alone each
year. Delayed cerebral ischemia occurs days after subarachnoid hemorrhage and …

OBJECTIVE Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating
cerebrovascular event with long-term morbidity and mortality. Patients who survive the initial …

Delayed cerebral ischemia (DCI) is the most feared complication of aneurysmal
subarachnoid hemorrhage (aSAH). It increases the mortality and morbidity associated with …